Key result
Thrombin accelerates cPLA2-catalyzed arachidonic acid liberation in human platelets through a non-proteolytic action toward PAR-1, independent of glycoprotein Ib.
This study demonstrates that thrombin enhances arachidonic acid liberation in human platelets via a non-proteolytic interaction with PAR-1, providing mechanistic insights into platelet activation.
Answers are grounded in this paper and cite their sources.
Non-proteolytic PAR-1 signaling may refine platelet activation models; leaves open clinical translation to antithrombotic strategies.
We investigated the regulation of arachidonic acid liberation catalyzed by group-IV cytosolic phospholipase A2 (cPLA2) in human platelets upon stimulation with thrombin through interaction with protease-activated receptor-1 (PAR-1) or glycoprotein Ib. Leupeptin, a protease inhibitor, completely inhibited thrombin-induced arachidonic acid liberation and Ca2+ mobilization, with inhibition of its protease activity. However, preincubation with thrombin in the presence of leupeptin potentiated Ca2+ ionophore-induced arachidonic acid liberation. The preincubation did not affect the intracellular Ca2+ level or cPLA2 activity in response to ionomycin. Human leukocyte elastase, which cleaves glycoprotein Ib, did not inhibit the enhancement of arachidonic acid liberation by thrombin in the presence of leupeptin. However, the effect of thrombin with leupeptin was abolished by a peptide corresponding to residues 54-65 of hirudin (hirudin peptide), which impairs the binding of thrombin to PAR-1. Furthermore, Phe-Pro-Arg chloromethyl ketone (PPACK)-thrombin, which binds to platelets but has no protease activity, also enhanced Ca2+ ionophore-induced arachidonic acid liberation. In contrast, trypsin with leupeptin did not mimic the effect of thrombin with leupeptin, and furthermore trypsin-induced arachidonic acid liberation was insensitive to hirudin peptide. On the basis of the present results, we suggest that thrombin may accelerate cPLA2-catalyzed arachidonic acid liberation through non-proteolytic action toward PAR-1 but not toward glycoprotein Ib in co-operation with the proteolytic action leading to Ca2+ mobilization.
No takes yet. Share an insight, caveat, or question.
Akiba et al. (1999) studied this question. Thrombin vs. Trypsin or no thrombin was evaluated on Arachidonic acid liberation and Ca2+ mobilization. Thrombin accelerates cPLA2-catalyzed arachidonic acid liberation in human platelets through a non-proteolytic action toward PAR-1, independent of glycoprotein Ib.
Synapse has enriched 10 related papers. Consider them for comparative context: